Stock listing

NASDAQ:EIDX Eidos Therapeutics Inc Stock

Follow Eidos Therapeutics Inc into a list and get an email when it puts out news.

Last close · NASDAQ:EIDX

$122.21 USD

Close on Jan 26, 2021 · No longer trades

Jun 20, 2018 to last close +428.6% · weekly closes, Jun 20, 2018 – Jan 26, 2021
Lowest – highest close
$9.20 – $131.58 USDSince Jun 20, 2018 · lowest Oct 11, 2018 · highest Dec 31, 2020

Delisted NASDAQ:EIDX no longer trades. Its last trading date is unknown. Company history and updates stay available on this page.

Ticker
NASDAQ:EIDX
Asset type
Stock
Exchange
NASDAQ
Currency
USD

Eidos Therapeutics Inc on 6ix

Decks
2 decks · latest Dec 29, 2020

Decks

DeckKindSlidesDate
Merger or Acquisition (December 2020)Merger or acquisition29 slidesDec 29, 2020
Investor Presentation (September 2020)Investor deck30 slidesSep 29, 2020

Open Decks

People

6ix reads each seat by machine from the page it links to, and can misread one.

PersonSeat
Rajeev M Shah
Other companies: Freenome, Inc. (Director · Since at least Jul 20, 2026); Parabilis Medicines, Inc. (Director · Since at least Jun 9, 2026); Hemab Therapeutics Holdings, Inc. (Director · Since at least Apr 30, 2026); SpyGlass Pharma, Inc. (Director · Since at least Feb 5, 2026); Evommune, Inc. (Director · Since at least Nov 5, 2025); Sionna Therapeutics, Inc. (Director · Since at least Feb 6, 2025); Septerna, Inc. (Director · Since at least Oct 24, 2024); Bicara Therapeutics Inc. (Director · Since at least Sep 12, 2024); Artiva Biotherapeutics, Inc. (Director · Since at least Jul 18, 2024); Cidara Therapeutics Inc (Director · Since at least Apr 24, 2024); LENZ Therapeutics, Inc. (Director · Since at least Mar 21, 2024); Mineralys Therapeutics, Inc. (Director · Since at least Feb 9, 2023); Acrivon Therapeutics, Inc. (Director · Since at least Nov 9, 2022); ARS Pharmaceuticals, Inc. (Director · Since at least Nov 8, 2022); PepGen Inc. (Director · Since at least May 5, 2022); Nkarta, Inc. (Director · Since at least Feb 14, 2022); Tyra Biosciences, Inc. (Director · Since at least Sep 14, 2021); Wave Life Sciences Ltd. (Director · Since at least Aug 16, 2021); Climb Bio, Inc. (Director · Since at least Aug 9, 2021); Acumen Pharmaceuticals, Inc. (Director · Since at least Jun 30, 2021); Janux Therapeutics, Inc. (Director · Since at least Jun 10, 2021); Vor Biopharma Inc. (Director · Since at least Feb 4, 2021); 89bio Inc (Director · Since at least Nov 8, 2019); Iteos Therapeutics Inc (Director · Jun 9, 2022 – Jun 9, 2022 · Past); Forma Therapeutics Holdings Inc (Director · Jun 8, 2022 – Jun 8, 2022 · Past); Icosavax Inc (Director · Jul 28, 2021 – Feb 19, 2024 · Past); Cytek Biosciences, Inc. (Director · Jul 22, 2021 – Mar 14, 2022 · Past); Jade Biosciences, Inc. (Director · Jun 29, 2021 – Jun 17, 2024 · Past); POINT Biopharma Global Inc (Director · Jun 23, 2021 – Jun 29, 2021 · Past); Werewolf Therapeutics, Inc. (Director · Apr 29, 2021 – May 12, 2025 · Past); Orchard Therapeutics PLC (Director · Feb 9, 2021 – Feb 9, 2021 · Past); Black Diamond Therapeutics, Inc. (Director · Jan 29, 2020 – Jul 5, 2023 · Past); Satsuma Pharmaceuticals Inc (Director · Sep 12, 2019 – Jun 6, 2023 · Past); Solid Biosciences Inc. (Director · Jan 25, 2018 – Jan 11, 2024 · Past); Kala Bio, Inc. (Director · Jul 19, 2017 – Jun 17, 2021 · Past); KalVista Pharmaceuticals, Inc. (Director · Nov 21, 2016 – Oct 12, 2017 · Past); Ra Pharmaceuticals Inc (Director · Oct 25, 2016 – Apr 2, 2020 · Past)
Director · Jun 19, 2018 – May 27, 2020 · Past
Franco Valle
Other companies: Biomea Fusion, Inc. (Chief Financial Officer · Jul 26, 2021 – Nov 30, 2024 · Past)
Senior Vice President, Finance · Oct 7, 2020 – Jan 26, 2021 · Past

Open People

Log in to ask 6ix AI your own questions about Eidos Therapeutics Inc.